Monogram Orthopaedics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	0.36	0	0.63	0	0	0	0
Cost of Revenue	0	0	0.46	0	0	0	0
Gross Profit	0.36	0	0.17	0	0	0	0
Selling, General & Admin	7.05	5.23	5.17	2.18	0.84	0.59	0.57
Research & Development	10.59	5.38	5.28	4.67	0.19	0.03	0.05
Other Operating Expenses	0	0	0	0	0.65	0.03	0
Operating Expenses	17.63	10.61	10.45	6.85	1.68	0.65	0.62
Operating Income	-17.27	-10.61	-10.28	-6.85	-1.68	-0.65	-0.62
Interest Expense / Income	0	0	0	0.05	0.12	0.06	0.02
Other Expense / Income	-3.52	3.08	1.54	2.16	-0	-0	0.01
Pretax Income	-13.75	-13.69	-11.81	-9.07	-1.8	-0.71	-0.66
Net Income	-13.75	-13.69	-11.81	-9.07	-1.8	-0.71	-0.66
Shares Outstanding (Basic)	22	10	10	9	6	0	0
Shares Outstanding (Diluted)	22	10	10	9	6	0	0
Shares Change	131.65%	-	5.94%	57.65%	2702.60%	17.72%	-
EPS (Basic)	-0.61	-1.42	-1.22	-0.99	-0.31	-3.44	-3.75
EPS (Diluted)	-0.61	-1.42	-1.22	-0.99	-0.31	-3.44	-3.75
Free Cash Flow	-13.61	-8.66	-9.2	-6.59	-1.05	-0.46	-0.77
Free Cash Flow Per Share	-0.61	-0.90	-0.95	-0.72	-0.18	-2.23	-4.39
Gross Margin	100.00%	-	26.99%	-	-	-	-
Operating Margin	-4730.98%	-	-1635.93%	-	-	-	-
Profit Margin	-3765.82%	-	-1880.63%	-	-	-	-
Free Cash Flow Margin	-3728.07%	-	-1464.25%	-	-	-	-
EBITDA	-13.33	-13.3	-11.49	-8.92	-1.64	-0.62	-0.62
EBITDA Margin	-3652.85%	-	-1829.38%	-	-	-	-
Depreciation & Amortization	0.41	0.39	0.32	0.1	0.03	0.03	0.01
EBIT	-13.75	-13.69	-11.81	-9.01	-1.67	-0.65	-0.64
EBIT Margin	-3765.82%	-	-1880.63%	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).